This invention belongs to the field of
biomedicine, specifically relating to a target for the treatment of
angiogenesis-related diseases and its applications. This invention provides a method for intervening in the
angiogenesis process by regulating the activity or expression level of Makorin
ring finger protein 1 (MKRN1). Applications of this invention cover the development of drugs that promote or inhibit
angiogenesis, the diagnosis and prognostic assessment of related diseases, and
drug screening based on this target.